# A little-known biotech’s high-stakes cancer bet just paid off and its shares doubled

- Source: CNBC Top News
- Published: 2026-11-03T09:35:47+00:00
- Category: Markets
- Original: https://www.cnbc.com/2026/11/03/genmab-cancer-drugs-petosemtamab.html
- Canonical: https://groundlevelnews.com/story/a-little-known-biotech-s-high-stakes-cancer-bet-just-paid-off-and-its--ac4e25/

Genmab’s shares have doubled in three months after a string of cancer drug trial wins, strengthening its push to own more of the medicines it develops.

_Ground Level News shows a short summary only; the full article and all rights belong to CNBC Top News._